Labor Induction with Synthetic Oxytocin and Infantile Colic: A Case-Control Study.
Suárez-Fraga. Cristina C; Rodríguez-Nogueira. Óscar Ó; Pinto-Carral. Arrate A; Leirós-Rodríguez. Raquel R; Álvarez-Álvarez. María José MJ
Key Findings
- Synthetic oxytocin used during labor was not associated with an increased risk of infantile colic (aOR 1.24; 95% CI 0.50-3.09).
- Epidural anesthesia predicted the use of synthetic oxytocin but did not independently affect colic risk.
- Infants with colic had a smaller average head circumference at birth, though this difference lost significance after adjusting for gestational age.
Practical Outcomes
- For biohackers and health enthusiasts, this research suggests that exposure to synthetic oxytocin in the delivery room does not appear to cause colic or feeding problems in infants, so it offers no actionable changes to adult protocols. The findings are mainly relevant to perinatal care rather than longevity or performance optimization.
Summary
A study of 76 newborns in Spain looked at whether the hormone oxytocin given to mothers during labor affects babies developing colic (excessive crying). They found no clear link between the drug and colic, and it also didn’t change how babies were fed. Babies with colic had slightly smaller heads at birth, but this finding wasn’t strong enough to be conclusive.
Abstract
<i>Background and Objectives</i>: Infantile colic affects 15-40% of infants ≤ 5 months, burdening families and health systems. While the effects of intrapartum oxytocin on neonatal outcomes have been widely investigated, its potential link with infantile colic remains poorly understood. We evaluated whether synthetic oxytocin is associated with infantile colic during the first five months of life and explored neonatal head circumference, feeding type and epidural anesthesia as additional factors. <i>Materials and Methods</i>: Prospective 1:1 matched case-control study in three Spanish pediatric outpatient clinics. Parents of 76 term infants aged 0-5 months (38 cases, 38 controls) completed face-to-face structured interviews documenting synthetic oxytocin and epidural use, infant anthropometry and feeding pattern. Infantile colic was diagnosed by Rome IV criteria. Associations were estimated with conditional logistic regression, producing adjusted odds ratios and 95% confidence intervals. <i>Results</i>: Synthetic oxytocin was used in 57.9% of deliveries and epidural anesthesia in 81.6%. Synthetic oxytocin showed no association with infantile colic (aOR 1.24; 95% CI 0.50-3.09). Epidural strongly predicted synthetic oxytocin exposure (aOR 4.55; 95% CI 1.28-16.20) but had no independent link to infantile colic. Infants with colic had a smaller mean head circumference at birth, although this difference did not remain significant after adjusting for gestational age, likely reflecting limited sample size. Synthetic oxytocin was not associated with breastfeeding status. <i>Conclusions</i>: In this cohort, intrapartum synthetic oxytocin was not related to infantile colic or to feeding difficulties. Smaller head circumference among colic cases may warrant further investigation as a potential risk marker. The high co-use of synthetic oxytocin and epidural underscores the need for larger longitudinal studies to clarify their peripartum-neonatal interactions.
Study Information
pubmed
2025
2025-10-24T00:00:00.000Z
10.3390/medicina61111908
18